Status: current, Defined. Date: 30-Sep 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3847311000168113 | Harvoni (ledipasvir 90 mg + sofosbuvir 400 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3847321000168118 | Harvoni tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Harvoni tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Harvoni tablet | has unit of use | tablet | true | Inferred relationship | Some | 1271742891 | |
| Harvoni tablet | has Australian BoSS | sofosbuvir | true | Inferred relationship | Some | 1271742890 | |
| Harvoni tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Harvoni tablet | Is a | Harvoni | true | Inferred relationship | Some | ||
| Harvoni tablet | Is a | ledipasvir 90 mg + sofosbuvir 400 mg tablet | true | Inferred relationship | Some | ||
| Harvoni tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Harvoni tablet | has Australian BoSS | ledipasvir | true | Inferred relationship | Some | 722906820 | |
| Harvoni tablet | has intended active ingredient | ledipasvir | true | Inferred relationship | Some | 722906820 | |
| Harvoni tablet | has intended active ingredient | sofosbuvir | true | Inferred relationship | Some | 1271742890 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Harvoni tablet, 28 | has TPUU | True | Harvoni tablet | Inferred relationship | Some | 1 |
| Harvoni tablet, 28, bottle | has TPUU | True | Harvoni tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR